F.A. Lefebvre

909 total citations
17 papers, 702 citations indexed

About

F.A. Lefebvre is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, F.A. Lefebvre has authored 17 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Reproductive Medicine. Recurrent topics in F.A. Lefebvre's work include Growth Hormone and Insulin-like Growth Factors (8 papers), Hormonal and reproductive studies (6 papers) and Hypothalamic control of reproductive hormones (5 papers). F.A. Lefebvre is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (8 papers), Hormonal and reproductive studies (6 papers) and Hypothalamic control of reproductive hormones (5 papers). F.A. Lefebvre collaborates with scholars based in Canada. F.A. Lefebvre's co-authors include Fernand Labrie, Carl Séguin, Jerry J. Reeves, Jean‐Pierre Raynaud, Paul A. Kelly, A. Bèlanger, L. Cusan, Vincent Giguère, Georges Pelletier and Alain Bélanger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Endocrinology and The Journal of Urology.

In The Last Decade

F.A. Lefebvre

17 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.A. Lefebvre Canada 13 395 316 172 150 141 17 702
Fernand Labrie Canada 13 265 0.7× 79 0.3× 64 0.4× 215 1.4× 232 1.6× 19 663
Yves Lachance Canada 7 731 1.9× 99 0.3× 47 0.3× 434 2.9× 442 3.1× 7 1.0k
Van Luu The Canada 7 463 1.2× 74 0.2× 27 0.2× 308 2.1× 327 2.3× 7 718
C. Malet France 10 203 0.5× 51 0.2× 33 0.2× 250 1.7× 420 3.0× 23 714
Y. Lachance Canada 7 346 0.9× 50 0.2× 78 0.5× 280 1.9× 160 1.1× 13 558
Yewei Xing United States 13 356 0.9× 63 0.2× 40 0.2× 235 1.6× 145 1.0× 17 607
A. M. Nakhla United States 7 167 0.4× 66 0.2× 78 0.5× 106 0.7× 107 0.8× 16 338
Juraj Osterman United States 16 139 0.4× 62 0.2× 29 0.2× 215 1.4× 78 0.6× 25 566
Marzia Becchis Italy 10 171 0.4× 101 0.3× 42 0.2× 123 0.8× 183 1.3× 12 356
S Sampérez France 13 243 0.6× 93 0.3× 15 0.1× 117 0.8× 143 1.0× 44 394

Countries citing papers authored by F.A. Lefebvre

Since Specialization
Citations

This map shows the geographic impact of F.A. Lefebvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.A. Lefebvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.A. Lefebvre more than expected).

Fields of papers citing papers by F.A. Lefebvre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.A. Lefebvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.A. Lefebvre. The network helps show where F.A. Lefebvre may publish in the future.

Co-authorship network of co-authors of F.A. Lefebvre

This figure shows the co-authorship network connecting the top 25 collaborators of F.A. Lefebvre. A scholar is included among the top collaborators of F.A. Lefebvre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.A. Lefebvre. F.A. Lefebvre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lefebvre, F.A., et al.. (1992). Thyroid hormone and androgen regulation of nerve growth factor gene expression in the mouse submandibular gland. Molecular and Cellular Endocrinology. 84(1-2). 145–154. 20 indexed citations
2.
Black, Michael A., Laura E. Pope, F.A. Lefebvre, Yvonne A. Lefebvre, & P. Walker. (1992). Thyroid hormones precociously increase nerve growth factor gene expression in the submandibular gland of neonatal mice.. Endocrinology. 130(4). 2083–2090. 13 indexed citations
3.
Raynaud, Jean‐Pierre, C. Bonne, M. Moguilewsky, et al.. (1984). The Pure Antiandrogen RU 23908 (Anandron), a Candidate of Choice for the Combined Antihormonal Treatment of Prostatic Cancer: A Review. The Journal of Urology. 132(5). 1065–1065. 3 indexed citations
4.
Lefebvre, F.A., A. Bèlanger, G. Pelletier, & Fernand Labrie. (1984). Recovery of Gonadal Functions in the Adult Male Rat Following Cessation of Five‐month Daily Treatment with an LHRH Agonist. Journal of Andrology. 5(3). 181–192. 11 indexed citations
5.
Raynaud, Jean‐Pierre, C. Bonne, M. Moguilewsky, et al.. (1984). The pure antiandrogen ru 23908 (anandron®), a candidate of choice for the combined antihormonal treatment of prostatic cancer: A review. The Prostate. 5(3). 299–311. 73 indexed citations
6.
Labrie, Fernand, A. Dupont, A. Bèlanger, et al.. (1983). New hormonal treatment in cancer of the prostate: Combined administration of an LHRH agonist and an antiandrogen. Journal of Steroid Biochemistry. 19(1). 999–1007. 35 indexed citations
7.
Labrie, Fernand, A. Dupont, A. Bèlanger, et al.. (1983). New Hormonal Therapy in Prostate Cancer: Combined Use of a Pure Antiandrogen and an LHRH Agonist. Hormone Research. 18(1-3). 18–27. 26 indexed citations
8.
Lefebvre, F.A., Carl Séguin, A. Bèlanger, et al.. (1982). Combined long‐term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat. The Prostate. 3(6). 569–578. 29 indexed citations
9.
Labrie, Fernand, Carl Séguin, F.A. Lefebvre, et al.. (1982). Intraovarian Actions of GnRH. Advances in experimental medicine and biology. 147. 211–222. 1 indexed citations
10.
Pelletier, G., Donald Dubé, J. Guy, Carl Séguin, & F.A. Lefebvre. (1982). Binding and Internalization of a Luteinizing Hormone-Releasing Hormone Agonist by Rat Gonadotrophic Cells. A Radioautographic Study. Endocrinology. 111(4). 1068–1076. 65 indexed citations
11.
Labrie, Fernand, A. Bèlanger, Carl Séguin, et al.. (1981). Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.. PubMed. 74. 273–91. 3 indexed citations
12.
Séguin, Carl, Alain Bélanger, L. Cusan, et al.. (1981). Relative Importance of the Adenohypophyseal and Gonadal Sites of Inhibitory Action of LHRH Agonists. Biology of Reproduction. 24(4). 889–901. 26 indexed citations
13.
Giguère, Vincent, F.A. Lefebvre, & Fernand Labrie. (1981). ANDROGENS DECREASE LHRH BINDING SITES IN RAT ANTERIOR PITUITARY CELLS IN CULTURE. Endocrinology. 108(1). 350–352. 66 indexed citations
14.
15.
Lefebvre, F.A., Jerry J. Reeves, Carl Séguin, Jocelyne Massicotte, & Fernand Labrie. (1980). Specific binding of a potent LHRH agonist in rat testis. Molecular and Cellular Endocrinology. 20(2). 127–134. 71 indexed citations
16.
Reeves, J. J., Carl Séguin, F.A. Lefebvre, Paul A. Kelly, & Fernand Labrie. (1980). Similar luteinizing hormone-releasing hormone binding sites in rat anterior pituitary and ovary.. Proceedings of the National Academy of Sciences. 77(9). 5567–5571. 80 indexed citations
17.
Labrie, Fernand, Alain Bélanger, L. Cusan, et al.. (1980). Antifertility Effects of LHRH Agonists in the Male. Journal of Andrology. 1(5). 209–228. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026